Research output per year
Research output per year
- 1 - 50 out of 78 results
Search results
-
2022
Author Correction: Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors (Investigational New Drugs, (2022), 40, 3, (596-605), 10.1007/s10637-022-01216-8)
Waqar, S. N., Robinson, C., Olszanski, A. J., Spira, A., Hackmaster, M., Lucas, L., Sponton, L., Jin, H., Hering, U., Cronier, D., Grinberg, M., Seithel-Keuth, A., Diaz-Padilla, I. & Berlin, J., Jun 2022, In: Investigational New Drugs. 40, 3, p. 679 1 p.Research output: Contribution to journal › Comment/debate
Open Access -
COVID-19 booster vaccines generate seroconversion in subset of patients with lymphoma/CLL: single institution experience
Mehta-Shah, N., Bartlett, N. L., Kahl, B., Watkins, M. P., Dubois, A., Schmelzle, G., Waqar, S., Ballman, C., Wan, F. & Farnsworth, C. W., 2022, (Accepted/In press) In: Leukemia and Lymphoma.Research output: Contribution to journal › Letter › peer-review
-
Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer
Knapp, B., Mezquita, L., Devarakonda, S., Aldea, M., Waqar, S. N., Pepin, K., Ward, J., Botticella, A., Howarth, K., Knape, C., Morris, C., Govindan, R., Besse, B. & Morgensztern, D., Mar 28 2022, In: Frontiers in Oncology. 12, 856132.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors
Bagegni, N. A., Park, H., Kraft, K., O-Toole, M., Gao, F., Waqar, S. N., Ratner, L., Morgensztern, D., Devarakonda, S., Amin, M., Baggstrom, M. Q., Liang, C., Selvaggi, G. & Wang-Gillam, A., Apr 2022, In: Cancer Chemotherapy and Pharmacology. 89, 4, p. 487-497 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer
Contreras, J., Srivastava, A., Samson, P., DeWees, T., Govindan, R., Baggstrom, M. Q., Morgensztern, D., Roach, M., Badiyan, S. N., Bradley, J., Waqar, S. & Robinson, C., 2022, (Accepted/In press) In: International Journal of Radiation Oncology Biology Physics.Research output: Contribution to journal › Article › peer-review
-
Phase I trial of ATM inhibitor M3541 in combination with palliative radiotherapy in patients with solid tumors
Waqar, S. N., Robinson, C., Olszanski, A. J., Spira, A., Hackmaster, M., Lucas, L., Sponton, L., Jin, H., Hering, U., Cronier, D., Grinberg, M., Seithel-Keuth, A., Diaz-Padilla, I. & Berlin, J., Jun 2022, In: Investigational New Drugs. 40, 3, p. 596-605 10 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer
Bogart, J. A., Waqar, S. N. & Mix, M. D., Feb 20 2022, In: Journal of Clinical Oncology. 40, 6, p. 661-670 10 p.Research output: Contribution to journal › Review article › peer-review
4 Scopus citations -
2021
Adjuvant Therapy with EGFR Tyrosine Kinase Inhibitors: Tempering Great Expectations with Realism
Waqar, S. N. & Govindan, R., Mar 1 2021, In: Journal of Clinical Oncology. 39, 7, p. 697-700 4 p.Research output: Contribution to journal › Review article › peer-review
-
A phase I/II study of rovalpituzumab tesirine in delta-like 3—expressing advanced solid tumors
Mansfield, A. S., Hong, D. S., Hann, C. L., Farago, A. F., Beltran, H., Waqar, S. N., Hendifar, A. E., Anthony, L. B., Taylor, M. H., Bryce, A. H., Tagawa, S. T., Lewis, K., Niu, J., Chung, C. H., Cleary, J. M., Rossi, M., Ludwig, C., Valenzuela, R., Luo, Y. & Aggarwal, R., Dec 2021, In: npj Precision Oncology. 5, 1, 74.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations
Devarakonda, S., Pellini, B., Verghese, L., Park, H., Morgensztern, D., Govindan, R., Suresh, R., Oppelt, P., Baggstrom, M. Q., Wu, N. & Waqar, S. N., Jul 2021, In: Journal of Thoracic Disease. 13, 7, p. 4054-4062 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A Phase II Study of Telisotuzumab Vedotin in Patients With c–MET-positive Stage IV or Recurrent Squamous Cell Lung Cancer (LUNG-MAP Sub-study S1400K, NCT03574753)
Waqar, S. N., Redman, M. W., Arnold, S. M., Hirsch, F. R., Mack, P. C., Schwartz, L. H., Gandara, D. R., Stinchcombe, T. E., Leighl, N. B., Ramalingam, S. S., Tanna, S. H., Raddin, R. S., Minichiello, K., Bradley, J. D., Kelly, K., Herbst, R. S. & Papadimitrakopoulou, V. A., May 2021, In: Clinical Lung Cancer. 22, 3, p. 170-177 8 p.Research output: Contribution to journal › Article › peer-review
9 Scopus citations -
A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors
Park, H., Williams, K., Trikalinos, N. A., Larson, S., Tan, B., Waqar, S., Suresh, R., Morgensztern, D., Van Tine, B. A., Govindan, R., Luo, J., Lockhart, A. C. & Wang-Gillam, A., Mar 2021, In: Cancer Chemotherapy and Pharmacology. 87, 3, p. 337-347 11 p.Research output: Contribution to journal › Article › peer-review
-
Genomic Profiling of Lung Adenocarcinoma in Never-Smokers
Devarakonda, S., Li, Y., Martins Rodrigues, F., Sankararaman, S., Kadara, H., Goparaju, C., Lanc, I., Pepin, K., Waqar, S. N., Morgensztern, D., Ward, J., Masood, A., Fulton, R., Fulton, L., Gillette, M. A., Satpathy, S., Carr, S. A., Wistuba, I., Pass, H., Wilson, R. K. & 2 others, , Nov 20 2021, In: Journal of Clinical Oncology. 39, 33, p. 3747-3758 12 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Molecular profiling-based assignment of cancer therapy (NCI-MPACT): A randomized multicenter phase II trial
Chen, A. P., Kummar, S., Moore, N., Rubinstein, L. V., Zhao, Y., Williams, P. M., Palmisano, A., Sims, D., O'Sullivan Coyne, G., Rosenberger, C. L., Simpson, M., Raghav, K. P. S., Meric-Bernstam, F., Leong, S., Waqar, S., Foster, J. C., Konaté, M. M., Das, B., Karlovich, C., Lih, C. J. & 5 others, , Jan 2021, In: JCO Precision Oncology. 5, p. 133-144 12 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies
Lim, K. H., Opyrchal, M., Acharya, A., Boice, N., Wu, N., Gao, F., Webster, J., Lockhart, A. C., Waqar, S. N., Govindan, R., Morgensztern, D., Picus, J., Tan, B. R., Baggstrom, M. Q., Maher, C. A. & Wang-Gillam, A., Sep 2021, In: European Journal of Cancer. 154, p. 102-110 9 p.Research output: Contribution to journal › Article › peer-review
-
Small Cell Lung Cancer, Version 2.2022
Ganti, A. K. P., Loo, B. W., Bassetti, M., Blakely, C., Chiang, A., D'Amico, T. A., D'Avella, C., Dowlati, A., Downey, R. J., Edelman, M., Florsheim, C., Gold, K. A., Goldman, J. W., Grecula, J. C., Hann, C., Iams, W., Iyengar, P., Kelly, K., Khalil, M., Koczywas, M. & 14 others, , Dec 2021, In: JNCCN Journal of the National Comprehensive Cancer Network. 19, 12, p. 1441-1464 24 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
SWOG S1400A (NCT02154490): A Phase II Study of Durvalumab for Patients With Previously Treated Stage IV or Recurrent Squamous Cell Lung Cancer (Lung-MAP Sub-study)
Borghaei, H., Redman, M. W., Kelly, K., Waqar, S. N., Robert, F., Kiefer, G. J., Stella, P. J., Minichiello, K., Gandara, D. R., Herbst, R. S. & Papadimitrakopoulou, V. A., May 2021, In: Clinical Lung Cancer. 22, 3, p. 178-186 9 p.Research output: Contribution to journal › Article › peer-review
-
2020
Demystifying the Role of Tumor Mutational Burden for Immunotherapy Selection - Reply
Waqar, S. N. & Govindan, R., 2020, In: JAMA oncology. 6, 11, p. 1809-1810 2 p.Research output: Contribution to journal › Letter › peer-review
-
Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer
Hassanzadeh, C., Sita, T., Savoor, R., Samson, P. P., Bradley, J., Gentile, M., Roach, M., Mohindra, N., Waqar, S., Kruser, T. J. & Robinson, C., Nov 2020, In: Journal of Thoracic Disease. 12, 11, p. 6690-6700 11 p.Research output: Contribution to journal › Article › peer-review
Open Access7 Scopus citations -
Olaparib and durvalumab in patients with germline BRCA-mutated metastatic breast cancer (MEDIOLA): an open-label, multicentre, phase 1/2, basket study
Domchek, S. M., Postel-Vinay, S., Im, S. A., Park, Y. H., Delord, J. P., Italiano, A., Alexandre, J., You, B., Bastian, S., Krebs, M. G., Wang, D., Waqar, S. N., Lanasa, M., Rhee, J., Gao, H., Rocher-Ros, V., Jones, E. V., Gulati, S., Coenen-Stass, A., Kozarewa, I. & 5 others, , Sep 2020, In: The Lancet Oncology. 21, 9, p. 1155-1164 10 p.Research output: Contribution to journal › Article › peer-review
97 Scopus citations -
Phase II Trial of Carfilzomib Plus Irinotecan in Patients With Small-cell Lung Cancer Who Have Progressed on Prior Platinum-based Chemotherapy
Arnold, S. M., Chansky, K., Baggstrom, M. Q., Thompson, M. A., Sanborn, R. E., Villano, J. L., Waqar, S. N., Hamm, J., Leggas, M., Willis, M., Rosales, J. & Crowley, J. J., Jul 2020, In: Clinical Lung Cancer. 21, 4, p. 357-364.e7Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
The Mystic Role of Tumor Mutational Burden in Selecting Patients with Lung Cancer for First-Line Immunotherapy
Waqar, S. N. & Govindan, R., May 2020, In: JAMA oncology. 6, 5, p. 674-675 2 p.Research output: Contribution to journal › Comment/debate
6 Scopus citations -
2019
Association between depth of response and survival in patients with advanced-stage non–small cell lung cancer treated with first-line chemotherapy
Morgensztern, D., Ko, A., O’Brien, M., Ong, T. J., Waqar, S. N., Socinski, M. A., Postmus, P. E. & Bhore, R., Jul 15 2019, In: Cancer. 125, 14, p. 2394-2399 6 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Circulating tumor (ct) DNA analysis to monitor response and resistance to ensartinib in patients (pts) with ALK+ non-small cell lung cancer (NSCLC)
Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Du, L., Hernandez, J., Huang, V., Waqar, S. N., Patel, S., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C., Lim, L. P., Li, M. & Lovly, C. M., Apr 2019, In: Annals of Oncology. 30, p. ii48Research output: Contribution to journal › Article › peer-review
Open Access -
Circulating tumor DNA profiling in small-cell lung cancer identifies potentially targetable alterations
Devarakonda, S., Sankararaman, S., Herzog, B. H., Gold, K. A., Waqar, S. N., Ward, J. P., Raymond, V. M., Lanman, R. B., Chaudhuri, A. A., Owonikoko, T. K., Li, B. T., Poirier, J. T., Rudin, C. M., Govindan, R. & Morgensztern, D., Oct 15 2019, In: Clinical Cancer Research. 25, 20, p. 6119-6126 8 p.Research output: Contribution to journal › Article › peer-review
14 Scopus citations -
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer
Horn, L., Whisenant, J. G., Wakelee, H., Reckamp, K. L., Qiao, H., Leal, T. A., Du, L., Hernandez, J., Huang, V., Blumenschein, G. R., Waqar, S. N., Patel, S. P., Nieva, J., Oxnard, G. R., Sanborn, R. E., Shaffer, T., Garg, K., Holzhausen, A., Harrow, K., Liang, C. & 3 others, , Nov 2019, In: Journal of Thoracic Oncology. 14, 11, p. 1901-1911 11 p.Research output: Contribution to journal › Article › peer-review
Open Access60 Scopus citations -
RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer
Morgensztern, D., Rose, M., Waqar, S. N., Morris, J., Ma, P. C., Reid, T., Brzezniak, C. E., Zeman, K. G., Padmanabhan, A., Hirth, J. A., I. Spira, A., Trepel, J. B. & Padda, S. K., Jul 30 2019, In: British Journal of Cancer. 121, 3, p. 211-217 7 p.Research output: Contribution to journal › Article › peer-review
Open Access19 Scopus citations -
SWOG S1400C (NCT02154490)—A Phase II Study of Palbociclib for Previously Treated Cell Cycle Gene Alteration–Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Substudy)
Edelman, M. J., Redman, M. W., Albain, K. S., McGary, E. C., Rafique, N. M., Petro, D., Waqar, S. N., Minichiello, K., Miao, J., Papadimitrakopoulou, V. A., Kelly, K., Gandara, D. R. & Herbst, R. S., Oct 2019, In: Journal of Thoracic Oncology. 14, 10, p. 1853-1859 7 p.Research output: Contribution to journal › Article › peer-review
Open Access32 Scopus citations -
2018
A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer and Systemic Inflammation
Giaccone, G., Sanborn, R. E., Waqar, S. N., Martinez-Marti, A., Ponce, S., Zhen, H., Kennealey, G., Erickson-Viitanen, S. & Schaefer, E., Sep 2018, In: Clinical Lung Cancer. 19, 5, p. e567-e574Research output: Contribution to journal › Article › peer-review
13 Scopus citations -
Clinical utility of cell-free DNA for the detection of ALK fusions and genomic mechanisms of ALK inhibitor resistance in non–small cell lung cancer
McCoach, C. E., Blakely, C. M., Banks, K. C., Levy, B., Chue, B. M., Raymond, V. M., Le, A. T., Lee, C. E., Diaz, J., Waqar, S. N., Purcell, W. T., Aisner, D. L., Davies, K. D., Lanman, R. B., Shaw, A. T. & Doebele, R. C., Jun 15 2018, In: Clinical Cancer Research. 24, 12, p. 2758-2770 13 p.Research output: Contribution to journal › Article › peer-review
Open Access98 Scopus citations -
Early Mortality in Patients Undergoing Adjuvant Chemotherapy for Non–Small Cell Lung Cancer
Morgensztern, D., Samson, P. S., Waqar, S. N., Devarakonda, S., Robinson, C. G., Govindan, R. & Puri, V., Apr 2018, In: Journal of Thoracic Oncology. 13, 4, p. 543-549 7 p.Research output: Contribution to journal › Article › peer-review
11 Scopus citations -
Ensartinib (X-396) in ALK-positive non–small cell lung cancer: Results from a first-in-human phase I/II, multicenter study
Horn, L., Infante, J. R., Reckamp, K. L., Blumenschein, G. R., Leal, T. A., Waqar, S. N., Gitlitz, B. J., Sanborn, R. E., Whisenant, J. G., Du, L., Neal, J. W., Gockerman, J. P., Dukart, G., Harrow, K., Liang, C., Gibbons, J. J., Holzhausen, A., Lovly, C. M. & Wakelee, H. A., Jun 15 2018, In: Clinical Cancer Research. 24, 12, p. 2771-2779 9 p.Research output: Contribution to journal › Article › peer-review
99 Scopus citations -
Immunogenicity of Influenza Vaccination in Patients with Cancer
Waqar, S. N., Boehmer, L., Morgensztern, D., Wang-Gillam, A., Sorscher, S., Lawrence, S., Gao, F., Guebert, K., Williams, K. & Govindan, R., 2018, In: American Journal of Clinical Oncology: Cancer Clinical Trials. 41, 3, p. 248-253 6 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Lorlatinib: a new-generation drug for ALK-positive NSCLC
Waqar, S. N. & Morgensztern, D., Dec 2018, In: The Lancet Oncology. 19, 12, p. 1555-1557 3 p.Research output: Contribution to journal › Comment/debate
5 Scopus citations -
Non–small-cell Lung Cancer With Brain Metastasis at Presentation
Waqar, S. N., Samson, P. P., Robinson, C. G., Bradley, J., Devarakonda, S., Du, L., Govindan, R., Gao, F., Puri, V. & Morgensztern, D., Jul 2018, In: Clinical Lung Cancer. 19, 4, p. e373-e379Research output: Contribution to journal › Article › peer-review
63 Scopus citations -
Paraneoplastic syndromes
Morgensztern, D., Waqar, S. N. & Govindan, R., Nov 16 2018, DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology. Wolters Kluwer Health Pharma Solutions (Europe) Ltd, p. 1998-2007 10 p.Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
-
Percutaneous Image-Guided Ablation in the Treatment of Osseous Metastases from Non-small Cell Lung Cancer
Ma, Y., Wallace, A. N., Waqar, S. N., Morgensztern, D., Madaelil, T. P., Tomasian, A. & Jennings, J. W., May 1 2018, In: Cardiovascular and Interventional Radiology. 41, 5, p. 726-733 8 p.Research output: Contribution to journal › Article › peer-review
20 Scopus citations -
Randomized, double-blind, phase II study of temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer
Pietanza, M. C., Waqar, S. N., Krug, L. M., Dowlati, A., Hann, C. L., Chiappori, A., Owonikoko, T. K., Woo, K. M., Cardnell, R. J., Fujimoto, J., Long, L., Diao, L., Wang, J., Bensman, Y., Hurtado, B., de Groot, P., Sulman, E. P., Wistuba, I. I., Chen, A., Fleisher, M. & 4 others, , Aug 10 2018, In: Journal of Clinical Oncology. 36, 23, p. 2386-2394 9 p.Research output: Contribution to journal › Article › peer-review
Open Access176 Scopus citations -
Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer
Wagner, A. H., Devarakonda, S., Skidmore, Z. L., Krysiak, K., Ramu, A., Trani, L., Kunisaki, J., Masood, A., Waqar, S. N., Spies, N. C., Morgensztern, D., Waligorski, J., Ponce, J., Fulton, R. S., Maggi, L. B., Weber, J. D., Watson, M. A., O’Conor, C. J., Ritter, J. H., Olsen, R. R. & 10 others, , Dec 1 2018, In: Nature communications. 9, 1, 3787.Research output: Contribution to journal › Article › peer-review
Open Access56 Scopus citations -
The impact of smoking and tp53 mutations in lung adenocarcinoma patients with targetable mutations—the lung cancer mutation consortium (LCMC2)
Aisner, D. L., Sholl, L. M., Berry, L. D., Rossi, M. R., Chen, H., Fujimoto, J., Moreira, A. L., Ramalingam, S. S., Villaruz, L. C., Otterson, G. A., Haura, E., Politi, K., Glisson, B., Cetnar, J., Garon, E. B., Schiller, J., Waqar, S. N., Sequist, L. V., Brahmer, J., Shyr, Y. & 7 others, , Mar 1 2018, In: Clinical Cancer Research. 24, 5, p. 1038-1047 10 p.Research output: Contribution to journal › Article › peer-review
109 Scopus citations -
2017
A phase 2, open-label, multi-center study of amuvatinib in combination with platinum etoposide chemotherapy in platinumrefractory small cell lung cancer patients
Byers, L. A., Horn, L., Ghandi, J., Kloecker, G., Owonikoko, T., Waqar, S. N., Krzakowski, M., Cardnell, R. J., Fujimoto, J., Taverna, P., Azab, M. & Camidge, D. R., 2017, In: Oncotarget. 8, 46, p. 81441-81454 14 p.Research output: Contribution to journal › Article › peer-review
Open Access8 Scopus citations -
Systemic Treatment of Brain Metastases
Waqar, S. N., Morgensztern, D. & Govindan, R., Feb 1 2017, In: Hematology/Oncology Clinics of North America. 31, 1, p. 157-176 20 p.Research output: Contribution to journal › Review article › peer-review
5 Scopus citations -
Treatment advances in small cell lung cancer (SCLC)
Waqar, S. N. & Morgensztern, D., Dec 2017, In: Pharmacology and Therapeutics. 180, p. 16-23 8 p.Research output: Contribution to journal › Review article › peer-review
94 Scopus citations -
2016
Adjuvant chemotherapy for patients with T2N0M0 NSCLC
Morgensztern, D., Du, L., Waqar, S. N., Patel, A., Samson, P., Devarakonda, S., Gao, F., Robinson, C. G., Bradley, J., Baggstrom, M., Masood, A., Govindan, R. & Puri, V., 2016, In: Journal of Thoracic Oncology. 11, 10, p. 1729-1735 7 p.Research output: Contribution to journal › Article › peer-review
Open Access52 Scopus citations -
A Phase i Trial of Temsirolimus and Pemetrexed in Patients with Advanced Non-Small Cell Lung Cancer
Waqar, S. N., Baggstrom, M. Q., Morgensztern, D., Williams, K., Rigden, C. & Govindan, R., Apr 1 2016, In: Chemotherapy. 61, 3, p. 144-147 4 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
Clinician perspectives on current issues in lung cancer drug development
Waqar, S. N., Bonomi, P. D., Govindan, R., Hirsch, F. R., Riely, G. J., Papadimitrakopoulou, V., Kazandjian, D., Khozin, S., Larkins, E., Dickson, D. J., Malik, S., Horn, L., Ferris, A., Shaw, A. T., Jänne, P. A., Mok, T. S. K., Herbst, R., Keegan, P., Pazdur, R. & Blumenthal, G. M., 2016, In: Journal of Thoracic Oncology. 11, 9, p. 1387-1396 10 p.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
Delayed nausea and vomiting from carboplatin doublet chemotherapy
Waqar, S. N., Mann, J., Baggstrom, M. Q., Waqar, M. A., Chitneni, P., Williams, K., Gao, F., Morgensztern, D. & Govindan, R., Jun 2 2016, In: Acta Oncologica. 55, 6, p. 700-704 5 p.Research output: Contribution to journal › Article › peer-review
Open Access9 Scopus citations -
Immune checkpoint inhibition in patients with brain metastases
Johanns, T., Waqar, S. N. & Morgensztern, D., Oct 2016, In: Annals of Translational Medicine. 4, S9.Research output: Contribution to journal › Editorial
10 Scopus citations -
Multimodality therapy for NSCLC
Du, L., Waqar, S. N. & Morgensztern, D., Jan 1 2016, Cancer Treatment and Research. Kluwer Academic Publishers, p. 151-163 13 p. (Cancer Treatment and Research; vol. 170).Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
5 Scopus citations -
Patterns of care in hilar node-positive (N1) non-small cell lung cancer: A missed treatment opportunity? Read at the 41st Annual Meeting of the Western Thoracic Surgical Association, Whistler, British Columbia, Canada, June 25, 2015.
Bott, M. J., Patel, A. P., Verma, V., Crabtree, T. D., Morgensztern, D., Robinson, C. G., Colditz, G. A., Waqar, S., Kreisel, D., Krupnick, A. S., Patterson, G. A., Broderick, S., Meyers, B. F. & Puri, V., Jun 1 2016, In: Journal of Thoracic and Cardiovascular Surgery. 151, 6, p. 1549-1558.e2Research output: Contribution to journal › Article › peer-review
Open Access28 Scopus citations